ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 387

$576K Total Retail Price of All Prescriptions

Rank: 113 out of 387

286 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 286 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 286 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 5,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
METFORMIN HCL 254 190 1 8
SIMVASTATIN 237 186 2 5
LEVOTHYROXINE SODIUM 224 182 3 2
POTASSIUM CHLORIDE 193 170 4 9
LISINOPRIL 192 135 5 3
FUROSEMIDE 190 166 6 7
AMLODIPINE BESYLATE 186 152 7 6
HYDROCODONE-ACETAMINOPHEN 171 140 S3 8 1
TRAMADOL HCL 166 103 9 14
METOPROLOL SUCCINATE 153 107 10 18
ATENOLOL 140 107 11 20
OMEPRAZOLE 129 95 12 4
METOPROLOL TARTRATE 128 111 13 11
WARFARIN SODIUM 125 116 14 17
ATORVASTATIN CALCIUM 115 107 15 13
HYDROCHLOROTHIAZIDE 111 110 16 12
SERTRALINE HCL 109 99 17 23
GABAPENTIN 100 77 18 10
CRESTOR 97 70 19 34
LOSARTAN POTASSIUM 90 86 20 24
CARVEDILOL 84 75 21 21
LYRICA 77 42 22 66
TAMSULOSIN HCL 75 71 23 32
ZOLPIDEM TARTRATE 74 50 24 16
ALLOPURINOL 73 53 25 28
CLOPIDOGREL 72 69 26 25
NEXIUM 70 41 27 26
AZITHROMYCIN 66 60 28 49
PANTOPRAZOLE SODIUM 64 52 29 48
GLIMEPIRIDE 60 58 30 50
ROPINIROLE HCL 59 55 31 91
DIOVAN 56 50 32 33
ADVAIR DISKUS 56 49 32 41
SPIRIVA 56 46 32 61
ZETIA 55 40 35 96
LEVOFLOXACIN 55 47 35 84
PRAVASTATIN SODIUM 52 44 37 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.